Why Running in Purple Speedos Is Serious Medicine for Men

Why Running in Purple Speedos Is Serious Medicine for Men

Picture a crowd of guys jogging through Johannesburg in nothing but bright purple swim briefs. On the surface, it looks like a stunt pulled straight from a college dare. Under the hood, though, that cheeky outfit is doing heavy lifting for prostate cancer awareness.

Every year, the Hollard Daredevil Run gets South African men to strip down to purple speedos—typically over a roughly 5 km route centered around Zoo Lake in Johannesburg, alongside regional runs and neighborhood sprints—to get people talking about men's cancers. If you've ever felt awkward bringing up a urologist visit or a blood test with your mates, you already get why a ridiculous uniform works. Embarrassment kills time, and with prostate cancer, time is the whole game.

Look at the stakes in South Africa. The Cancer Association of South Africa (CANSA) cites a lifetime risk of 1 in 17 for South African men based on the 2024 National Cancer Registry, while global data from Globocan points to prostate cancer as the most commonly diagnosed cancer in South Africa. Worse still, Black African men face roughly 2.5 times higher risk and about 2.5 times higher mortality compared to other population groups. A 5 km trot in skimpy swimwear won't cure a tumor, obviously. Still, it cracks open a door men usually keep bolted shut.

Why Cheeky Attire Breaks Through Male Silence

Let's be real for a second. Most men don't wake up eager to chat about urinary changes, pelvic discomfort, or screening tests over Sunday braai smoke. We're conditioned to tough it out, brush off weird body signals, and wait until something hurts so badly we can't ignore it.

That's the exact trap prostate cancer loves. Early-stage prostate cancer rarely causes obvious symptoms. You can feel completely fit, run long distances, lift heavy, and still have cellular changes brewing quietly inside a small walnut-sized gland below the bladder. By the time classic warning signs show up—like trouble starting or stopping urine flow, a weak stream, blood in the urine or semen, erectile issues, persistent fatigue, unexplained weight loss, or bone pain—the disease may already be further along.

Wearing purple briefs flips the script. You can't blend into the background when you're jogging past commuters in bright swimwear. Strangers stare, friends tease, and suddenly everyone's asking what the run is for. That awkward five-second question creates space for real talk—about fathers, brothers, uncles, and checkups men keep putting off.

What the Hollard Daredevil Run Actually Funds

Fun runs can easily turn into empty photo ops if the money vanishes into T-shirt printing and event staging. Here, the financial trail is pretty clear. Proceeds from the Hollard Daredevil Run go toward CANSA and the Prostate Cancer Foundation of South Africa, funding public education, patient navigation and support networks, helpline services, and community screening outreach.

In 2025, the event raised R1.2 million for CANSA and the Prostate Cancer Foundation, building on R1 million raised in 2024. For the Prostate Cancer Foundation, that annual contribution is its single largest donation of the year. It helps pay for multilingual educational materials and supports mobile screening efforts, including the Hollard MANVan and CANSA outreach clinics, reaching men who don't have easy access to routine testing.

The money has also helped back the launch of South Africa's first comprehensive prostate cancer registry in the second half of 2026. Why does a registry matter so much? Because you can't fix blind spots in care if you don't have accurate, nationwide numbers on diagnosis, treatment pathways, and survival outcomes.

The Harsh Reality Behind Late Diagnoses

Here's the uncomfortable truth you won't get from a cheerful event recap. Survival numbers when prostate cancer is caught early are remarkably encouraging—CANSA notes a 95% survival rate when detected early, and localized prostate cancer carries a 5-year survival rate above 98% or even over 99% depending on the specific cohort and reporting metric.

Yet too many men show up late. A 2026 South African study by researchers at Walter Sisulu University underscored how common late presentation remains, pointing to early-detection gaps, delayed referrals, and uneven access to screening. Meanwhile, research among men in Limpopo in 2023 found that nearly two-thirds had inadequate awareness of prostate cancer and over 80% didn't know how screening works.

Think about that gap. The medical upside of catching the disease early is huge, yet basic awareness and screening access still lag behind. Awareness campaigns alone don't solve clinic bottlenecks or transport costs, so pairing visibility with mobile testing and patient support is honestly the smartest way to bridge both sides of the problem.

Prostate Versus Testicular Cancer in the Same Spotlight

Because the event highlights both prostate and testicular cancer, people sometimes lump them together as if they're the same thing. They aren't.

Prostate cancer mainly affects older men and men with higher inherited or demographic risk, developing slowly in the prostate gland. Testicular cancer is far less common overall, yet it hits younger men—often between ages 15 and 49—and typically shows up first as a lump or swelling in a testicle. When caught early, testicular cancer also has strong survival outcomes.

Putting both on the same stage makes practical sense for men's health, though. Whether a guy is 24 checking for unusual testicular changes or 48 weighing a baseline blood test, the core habit is identical: pay attention to your body, don't let stigma keep you quiet, and get checked before trouble escalates.

Screening Isn't One Size Fits All

Let's clear up a common misconception about screening. Getting a PSA blood test—which measures prostate-specific antigen, a protein produced by the prostate—doesn't mean you automatically have cancer if the number is elevated. Prostate enlargement, inflammation, or infection can also raise PSA levels. A high reading simply flags that you need a closer look, potentially including follow-up tests or a referral to a urologist.

Guidance also depends on your personal risk profile rather than a single universal rule:

  • Higher-risk men, including Black African men or those with a family history of prostate cancer (especially a father or brother diagnosed young) or certain family cancer histories like breast cancer, are generally advised to discuss annual PSA screening starting around age 40.
  • Men at average risk are commonly guided to start screening discussions around age 45, while CANSA also outlines routine PSA and physical exam schedules starting from age 45 to 50 depending on risk factors.

There's also legitimate medical debate around over-screening and over-treatment of slow-growing tumors in older men. That's why talking through your age, family history, and personal preferences with a doctor matters more than blindly chasing a lab number.

Practical Steps You Can Take This Week

You don't need to wait for October or slip into purple swimwear to do something meaningful. Start with a few concrete moves:

  1. Map your family history. Ask close relatives about prostate cancer—and note any family history of breast cancer too—since inherited factors play a major role in risk.
  2. Book a baseline conversation. If you're in your 40s or 50s, or have higher risk factors, schedule a visit at a local clinic, GP, or mobile screening unit to ask whether a PSA test makes sense for you right now.
  3. Don't wait for red flags. Treat feeling healthy as a reason to stay proactive, not a reason to skip a checkup.
  4. Start one honest conversation. Bring up men's health with a brother, partner, teammate, or friend—sometimes saying the awkward part out loud is what gets someone else through the clinic door.
HB

Hannah Brooks

Hannah Brooks is passionate about using journalism as a tool for positive change, focusing on stories that matter to communities and society.